In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003.
about
Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparumMalaria in the Greater Mekong Subregion: heterogeneity and complexityDeclining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand borderChanges in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deploymentDeployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria InitiativeCurrent status of artemisinin-resistant falciparum malaria in South Asia: a randomized controlled artesunate monotherapy trial in BangladeshTackling the malaria problem in the South-East Asia Region: need for a change in policy?Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern CambodiaThe clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon.Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations.Absorption, distribution, excretion, and pharmacokinetics of 14C-pyronaridine tetraphosphate in male and female Sprague-Dawley ratsDecreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007Malaria and other vector-borne infection surveillance in the U.S. Department of Defense Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance program: review of 2009 accomplishments.Preliminary investigation of the contribution of CYP2A6, CYP2B6, and UGT1A9 polymorphisms on artesunate-mefloquine treatment response in Burmese patients with Plasmodium falciparum malaria.Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border.Emerging artemisinin resistance in the border areas of Thailand.Artemisinin Antimalarials: Preserving the "Magic Bullet"Sequence and gene expression of chloroquine resistance transporter (pfcrt) in the association of in vitro drugs resistance of Plasmodium falciparumMonitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010.Multiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in CambodiaDiscovery, mechanisms of action and combination therapy of artemisininDose ranging studies of new artemisinin-piperaquine fixed combinations compared to standard regimens of artemisisnin combination therapies for acute uncomplicated falciparum malariaEfficacy of Artequick versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand.Polymorphisms of molecular markers of antimalarial drug resistance and relationship with artesunate-mefloquine combination therapy in patients with uncomplicated Plasmodium falciparum malaria in Thailand.Selection and spread of artemisinin-resistant alleles in Thailand prior to the global artemisinin resistance containment campaignIn vivo antimalarial evaluation of some 2,3-disubstituted-4(3H)-quinazolinone derivatives.Ex vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidine-rich protein-2 assayArtemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering CambodiaDelayed Plasmodium falciparum clearance following artesunate-mefloquine combination therapy in Thailand, 1997-2007.In vitro-reduced susceptibility to artemether in P. falciparum and its association with polymorphisms on transporter genesPopulation pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border.Molecular surveillance for multidrug-resistant Plasmodium falciparum, Cambodia.Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity.A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study.Distribution of pfmdr1 polymorphisms in Plasmodium falciparum isolated from Southern Thailand.Molecular analysis demonstrates high prevalence of chloroquine resistance but no evidence of artemisinin resistance in Plasmodium falciparum in the Chittagong Hill Tracts of Bangladesh.Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.Prevalence of K13 mutation and Day-3 positive parasitaemia in artemisinin-resistant malaria endemic area of Cambodia: a cross-sectional study.Drug resistance and in vitro susceptibility of Plasmodium falciparum in Thailand during 1988-2003
P2860
Q21032477-6D5048F9-E630-4EDF-B27C-B6DF3707B6BBQ21032492-462F540C-7360-4F8A-A538-3AD86821A646Q21032539-6758B4E1-AC4A-4844-8B33-289A8610C7D4Q21090072-6A62A145-FE04-4027-B747-0BE2430D1905Q28469264-10CE3C86-9193-4ECC-9A15-21A0C3783678Q28484416-7C1395E7-3D1C-451E-A81F-1CCEFC3519CAQ30597566-80A1CB8F-9257-401E-AEDF-E3AC52EF8605Q33399259-6E5D4ED3-9FE1-454E-BCA9-62A6A0127862Q33655603-F359962B-8A68-49EB-A712-F7BC76C7CF56Q33711903-4536C518-5B33-4A90-8074-94AEE6351C86Q33723453-BBB385B9-6DB4-4AF0-B2F2-7FBCE6DBF716Q33772005-8627C47B-0B9F-4661-8AB2-511F56A566E5Q33826378-91C0C501-8E57-4CFE-A148-C2C7D32411B8Q33841526-510458EC-51D6-48F0-B821-3368C509AA62Q34015980-BA80FA1D-DC9F-4E2E-8A51-A1AA18F4DECDQ34221869-8A351B1A-5FD4-44BB-8741-0E53A82B4069Q34343530-E817C4D3-B6C3-4DC0-AEB4-CA499F7FC9EBQ34622342-D138E07A-C5CB-4EA0-BD2B-96D1D1BDE2EAQ34660017-C24765BF-68DC-4E5E-8682-49C532F73EC7Q34660024-0D12C1E0-F069-4DD8-AAEC-C8F70BA72FAFQ34986023-817E9357-E606-4041-90F3-F685CC8D184FQ35006418-6EE1284C-294F-40EC-AA47-8AF2767634D3Q35043511-120DC586-AB12-4571-A929-B554A471E5E1Q35086214-E653B5D8-B7EA-4913-A9DC-448FC67CCED8Q35186886-2E985389-E6E4-4D81-ADD6-F3C4A3792FD7Q35594027-1CB30DCD-EB2F-4AFE-9AD0-1AAAC19E72A7Q35815377-2E37749D-DF5A-4F1B-9D5C-ED575EF2276DQ36112839-1B2577DD-4F3D-432B-9607-6C2EC7A5C9ADQ36243910-0D492CC8-8ADA-424B-A24C-C6DBBA806479Q36338542-B82A8C0F-954B-4AF7-954D-EBE5187B8F5AQ36376217-25737496-842B-48C4-8E4E-830615E65563Q36634918-6927A71B-44C8-4EB5-917C-6C997261BCCDQ37028467-C9E8AF16-44F1-4C88-BF7E-5A7812E1A440Q37079427-11416CC7-AEE1-4A19-97C9-291ACC1A3AEDQ37254756-295FDD8D-89E4-4240-BEDF-1E69EAA93084Q38755875-90FDC162-B803-4CC4-895D-879674933D7DQ38866966-96B33EB1-3066-49F6-A228-3AC08B500624Q39060005-644D4F75-62AC-43CD-82AD-F3CF0C3C8B40Q41108032-137E32A5-6E7F-4FD9-B342-8396706E5A1DQ41760734-6B80E89B-2483-42B2-ABC4-EDB84C5811C5
P2860
In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
In vivo sensitivity monitoring ...... m malaria in Thailand in 2003.
@en
type
label
In vivo sensitivity monitoring ...... m malaria in Thailand in 2003.
@en
prefLabel
In vivo sensitivity monitoring ...... m malaria in Thailand in 2003.
@en
P2093
P2860
P921
P1476
In vivo sensitivity monitoring ...... m malaria in Thailand in 2003.
@en
P2093
Argat Nakavej
Chaiporn Rojanawatsirivej
Chansuda Wongsrichanalai
Duangduen Phoungmanee
Saowanit Vijaykadga
Sawat Cholpol
P2860
P304
P356
10.1111/J.1365-3156.2005.01557.X
P577
2006-02-01T00:00:00Z